Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Tax Provisions: 2009-2025

Historic Tax Provisions for Lifecore Biomedical (LFCR) over the last 12 years, with May 2025 value amounting to $33,000.

  • Lifecore Biomedical's Tax Provisions rose 157.89% to $33,000 in Q2 2025 from the same period last year, while for May 2025 it was $43,000, marking a year-over-year decrease of 76.50%. This contributed to the annual value of $43,000 for FY2025, which is 76.50% down from last year.
  • Lifecore Biomedical's Tax Provisions amounted to $33,000 in Q2 2025, which was up 512.50% from -$8,000 recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical's Tax Provisions peaked at $3.4 million during Q1 2022, and registered a low of -$6.3 million during Q4 2021.
  • Over the past 3 years, Lifecore Biomedical's median Tax Provisions value was $38,000 (recorded in 2024), while the average stood at $52,600.
  • Data for Lifecore Biomedical's Tax Provisions shows a peak YoY increase of 2,100.00% (in 2023) and a maximum YoY decrease of 1,725.00% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Tax Provisions stood at -$6.3 million in 2021, then surged by 100.06% to $4,000 in 2022, then plummeted by 1,725.00% to -$65,000 in 2023, then soared by 166.15% to $43,000 in 2024, then spiked by 157.89% to $33,000 in 2025.
  • Its Tax Provisions was $33,000 in Q2 2025, compared to -$8,000 in Q1 2025 and $43,000 in Q4 2024.